Company Filing History:
Years Active: 2021
Title: Maki Deguchi: Innovator in Antibody Development
Introduction
Maki Deguchi is a prominent inventor based in Kobe, Japan. She has made significant contributions to the field of biotechnology, particularly in the development of antibodies. With a total of 2 patents, her work focuses on enhancing therapeutic options for various medical conditions.
Latest Patents
Maki Deguchi's latest patents include an innovative anti-EphA4 antibody. This antibody is designed to bind to EphA4 and enhance its cleavage, providing a pharmaceutical composition that includes the antibody as the active ingredient. The development process involved obtaining a mouse anti-EphA4 antibody with a strong binding affinity towards EphA4. The sequence of the complementarity-determining region (CDR) of this mouse antibody was identified, leading to the production of a humanized version of the antibody for further therapeutic applications.
Career Highlights
Maki Deguchi is currently associated with Eisai R&D Management Co., Ltd., where she continues her research and development efforts. Her work has been instrumental in advancing the understanding and application of antibodies in medical treatments.
Collaborations
Maki has collaborated with notable colleagues, including Eiji Inoue and Akio Yamada, to further enhance her research initiatives and patent developments.
Conclusion
Maki Deguchi's contributions to antibody research exemplify her innovative spirit and dedication to improving healthcare solutions. Her patents reflect a commitment to advancing medical science through targeted therapeutic strategies.